Dose intensity phase I II trial with ifosfamide, carboplatin, etoposide, and vincristine combined with filgastrim (CEV-Ifo + G) in patients with small-cell lung cancer (SCLC)
Titel:
Dose intensity phase I II trial with ifosfamide, carboplatin, etoposide, and vincristine combined with filgastrim (CEV-Ifo + G) in patients with small-cell lung cancer (SCLC)
Auteur:
Hanauske, A-R Korfel, A Perker, M Heinrich, B Schwab, G Graf, M Depenbrock, H Höffken, G Kreuser, E Thiel, E Zwingers, T Berdel, W